[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Sarepta Sarepta Therapeutics Sarepta Therapeutics posts on X about the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::2216555822/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +31% - X Months XXXXXX +491% - X Year XXXXXX -XX% ### Mentions: X [#](/creator/twitter::2216555822/posts_active)  - X Week XX -XX% - X Month XX +21% - X Months XX +94% - X Year XX +175% ### Followers: XXXXX [#](/creator/twitter::2216555822/followers)  - X Week XXXXX +1.80% - X Month XXXXX +3.50% - X Months XXXXX +7.50% - X Year XXXXX +13% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::2216555822/influencer_rank)  ### Social Influence [#](/creator/twitter::2216555822/influence) --- **Top accounts mentioned or mentioned by** [@yachmod](/creator/undefined) [@cphilstrom](/creator/undefined) [@genbio](/creator/undefined) [@parentprojectmd](/creator/undefined) [@jmaraganore](/creator/undefined) [@alexwestchester](/creator/undefined) [@yasiejko](/creator/undefined) [@marksharkking](/creator/undefined) [@mdaorg](/creator/undefined) [@duncanburnsma](/creator/undefined) [@yaireinhorn](/creator/undefined) [@stock_truth](/creator/undefined) [@yusufhameed](/creator/undefined) [@pharmacompass](/creator/undefined) [@superduperdrugs](/creator/undefined) [@defeatduchenne](/creator/undefined) [@paulmarganski](/creator/undefined) [@cureduchenne](/creator/undefined) [@zinselmeyerb](/creator/undefined) [@rwarner42](/creator/undefined) ### Top Social Posts [#](/creator/twitter::2216555822/posts) --- Top posts by engagements in the last XX hours "News: The U.S. FDA granted Platform Technology Designation to SRP-9003 Sareptas investigational gene therapy for the treatment of LGMD type 2E/R4. This is one of the first programs to receive the technology designation. Read more at"  [@Sarepta](/creator/x/Sarepta) on [X](/post/tweet/1930272306384793816) 2025-06-04 14:35:55 UTC 6182 followers, 8014 engagements "Today we issued a safety update for our approved gene therapy. Read here:"  [@Sarepta](/creator/x/Sarepta) on [X](/post/tweet/1901979516135780640) 2025-03-18 12:50:28 UTC 6177 followers, 2930 engagements "Today we shared updates from our clinical programs focused on limb-girdle muscular dystrophy (LGMD) subtypes 2C/R5 2D/R3 and 2E/R4. Read more here:"  [@Sarepta](/creator/x/Sarepta) on [X](/post/tweet/1912122376738779536) 2025-04-15 12:34:34 UTC 6173 followers, 3423 engagements "Excited to be a partner of the 2025 @MDAorg Clinical & Scientific Conference. Well be there celebrating XX years of #MDA impact & sharing updates on how Sarepta is advancing science for Duchenne and LGMD patients. #MDAconference"  [@Sarepta](/creator/x/Sarepta) on [X](/post/tweet/1900643260193784031) 2025-03-14 20:20:40 UTC 6181 followers, 2773 engagements "Today we announced a licensing and collaboration agreement with Arrowhead Pharmaceuticals that will provide Sarepta with exclusive global rights to multiple clinical pre-clinical and discovery stage programs for rare genetic diseases"  [@Sarepta](/creator/x/Sarepta) on [X](/post/tweet/1861380714509267057) 2024-11-26 12:05:19 UTC 6182 followers, 7922 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Sarepta Sarepta Therapeutics
Sarepta Therapeutics posts on X about the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX +31%
- X Months XXXXXX +491%
- X Year XXXXXX -XX%
Mentions: X #
- X Week XX -XX%
- X Month XX +21%
- X Months XX +94%
- X Year XX +175%
Followers: XXXXX #
- X Week XXXXX +1.80%
- X Month XXXXX +3.50%
- X Months XXXXX +7.50%
- X Year XXXXX +13%
CreatorRank: XXXXXXXXX #
Social Influence #
Top accounts mentioned or mentioned by @yachmod @cphilstrom @genbio @parentprojectmd @jmaraganore @alexwestchester @yasiejko @marksharkking @mdaorg @duncanburnsma @yaireinhorn @stock_truth @yusufhameed @pharmacompass @superduperdrugs @defeatduchenne @paulmarganski @cureduchenne @zinselmeyerb @rwarner42
Top Social Posts #
Top posts by engagements in the last XX hours
"News: The U.S. FDA granted Platform Technology Designation to SRP-9003 Sareptas investigational gene therapy for the treatment of LGMD type 2E/R4. This is one of the first programs to receive the technology designation. Read more at"
@Sarepta on X 2025-06-04 14:35:55 UTC 6182 followers, 8014 engagements
"Today we issued a safety update for our approved gene therapy. Read here:" @Sarepta on X 2025-03-18 12:50:28 UTC 6177 followers, 2930 engagements
"Today we shared updates from our clinical programs focused on limb-girdle muscular dystrophy (LGMD) subtypes 2C/R5 2D/R3 and 2E/R4. Read more here:" @Sarepta on X 2025-04-15 12:34:34 UTC 6173 followers, 3423 engagements
"Excited to be a partner of the 2025 @MDAorg Clinical & Scientific Conference. Well be there celebrating XX years of #MDA impact & sharing updates on how Sarepta is advancing science for Duchenne and LGMD patients. #MDAconference" @Sarepta on X 2025-03-14 20:20:40 UTC 6181 followers, 2773 engagements
"Today we announced a licensing and collaboration agreement with Arrowhead Pharmaceuticals that will provide Sarepta with exclusive global rights to multiple clinical pre-clinical and discovery stage programs for rare genetic diseases" @Sarepta on X 2024-11-26 12:05:19 UTC 6182 followers, 7922 engagements